Celeste Krewson, Assistant Editor

In a recent study, different intrapartum transperineal ultrasound methods showed improved accuracy when predicting failed or complicated operative vaginal birth.

The North American Menopause Society is now known as The Menopause Society.

In a recent study, monozygotic twins with an increased birth rate had fewer autism traits and intellectual disability ratings.

A recent article highlighted 6 bottlenecks which must be addressed to improve gender equity in biomedical research.

In a recent study, the risk of cervical intraepithelial neoplasia recurrence was reduced in patients using imiquimod.

In a recent study, increased rates of severe maternal morbidity were observed among hospitals with a lower obstetric volume in rural settings, but not urban settings.

The White House has announced the signing of an executive order from President Biden to allow easier access to contraception in the United States.

In a recent study, decreased use of long acting and permanent methods of contraception was found among patients with opioid use disorder.

A blood test to determine the risks of preeclampsia and severe preeclampsia in pregnant patients has been given approval by the FDA.

A recent article outlined the risk factors, symptoms, and treatment methods associated with premature ovarian insufficiency.

Beth A. Prairie MD MPH FACOG FACPM, discusses how alcohol consumption worsens symptoms of menopause in midlife women.

In a recent study, pregnancies with preterm prelabor rupture of membranes were associated with greater risks of intraamniotic infection, microbial invasion of the amniotic cavity without inflammation, and early-onset neonatal sepsis development in women with a history of cervical excisional treatment.

Hugh Taylor, MD, discusses topic which will be presented at the 4th Annual International Congress on the Future of Women’s Health.

In a recent study, no clinically significant changes in ovarian reserve were found based on COVID-19 vaccination status.

Astellas has announced positive results of a trial evaluating the safety and efficacy of fezolinetant in menopausal women with moderate to severe vasomotor symptoms.

In a recent review, hormone therapy use was associated with gastroesophageal reflux disease.

In a recent review, the associations between components of lifestyle interventions and reductions in gestational weight gain were unclear.

In a recent study, women diagnosed with attention deficit hyperactivity disorder were at a 24% increased risk of postpartum depression.

In a recent study, rates of maternal morbidity increased in 2021 compared to 2008, while in-hospital mortality rates were reduced.

Johnson & Johnson has announced positive safety and efficacy results in a phase 2 trial evaluating nipocalimab against early-onset severe hemolytic disease of the fetus and newborn.

In a recent study, decreased risks of stroke after pregnancy were seen among women with pregnancy-associated stroke compared to those with non-pregnancy-associated stroke.

In a recent study, higher rates of cardiovascular disease incidence were observed in women who received a hysterectomy when aged under 50 years compared to women without a hysterectomy.

In a recent study, positive safety and efficacy were found in patients taking mifepristone against adenomyosis.

Daré Bioscience has published new data on the safety and pharmacokinetics of DARE-HRT1.

In a recent study, pregnant individuals residing in neighborhoods with greater densities of unhealthy food were at an increased risk of giving birth to infants who were small for gestational age or large for gestational age.

A recent study associated increased risk of diabetes incidence after pregnancy in individuals who developed gestational diabetes during pregnancy.

In a recent study, beliefs on cannabis use during pregnancy were not associated with exposure to warning signs.

The 4th Annual International Congress on the Future of Women’s Health will cover topics on diagnosis and treatment in women’s health.

In a recent study, participants with 4 or more adverse childhood experiences were more likely to experience increased epigenetic age acceleration.

In a recent study, increased risks of adverse pregnancy, delivery, and neonatal outcomes were found among women with obsessive-compulsive disorder.